Semaglutide Research
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity
Nature Medicine·March 1, 2026
Steven B. Heymsfield, Ania M. Jastreboff, et al.
Summary
Novel combination therapy targeting both fat loss (semaglutide) and muscle preservation (bimagrumab) for obesity treatment.
Study Details
Study Design
Randomized controlled trial
Indication
Obesity
Intervention
Bimagrumab plus semaglutide alone or in combination
Species
Human